Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE: Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS: To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION: By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity. A crippled CRISPR/Cas targets AID.: In vertebrate adaptive immunity, cytosine deaminase (AID or PmCDA1) induces somatic hypermutation at single-stranded DNA regions formed during transcription. The bacterial CRISPR/Cas9 immunity system recognizes and cleaves invasive DNA in a gRNA-dependent manner. AID and nuclease-deficient CRISPR/Cas9 are engineered to form a hybrid complex (Target-AID) that performs programmable cytosine mutations in a range of a few bases surrounding the –18 position upstream of PAM sequence of the noncomplementary DNA strand.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., & Church, G. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt135 · Cited by 1,566
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Cited by
Items 501–600 of 1,001
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering
Glinšek, K., Bozovičar, K., & Bratkovič, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098144 · Cited by 42
Base editors: development and applications in biomedicine
Liang, Y., Chen, F., Wang, K., & Lai, L. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1013-y · Cited by 35
Structure and engineering of miniature Acidibacillus sulfuroxidans Cas12f1
Wu, Z., Liu, D., Pan, D. Y., Yu, H., Shi, J. F., Ma, J., Fu, W., Wang, Z., Zheng, Z., Qu, Y., et al. (2023) · Nature Catalysis · doi:10.1038/s41929-023-00995-4 · Cited by 34
Xu, K., Feng, H., Zhang, H., He, C., Kang, H., Yuan, T., Shi, L., Zhou, C., Hua, G., Cao, Y., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01220-8 · Cited by 37
Hsu, C., Cheng, Y., Yuan, Y.-H., Hung, W.-F., Cheng, Q., Wu, F., Lee, L., Gelvin, S. B., & Lin, C. (2019) · Plant Molecular Biology · doi:10.1007/s11103-019-00907-w · Cited by 33
Programming PAM antennae for efficient CRISPR-Cas9 DNA editing
Wang, F., Hao, Y., Li, Q., Li, J., Zhang, H., Zhang, X., Wang, L., Bustamante, C., & Fan, C. (2020) · Science Advances · doi:10.1126/sciadv.aay9948 · Cited by 36
Genome editing systems across yeast species
Yang, Z., & Blenner, M. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.08.011 · Cited by 41
Stress tolerance enhancement via SPT15 base editing in Saccharomyces cerevisiae
Liu, Y., Lin, Y., Guo, Y., Wu, F., Zhang, Y., Qi, X., Wang, Z., & Wang, Q. (2021) · Biotechnology for Biofuels · doi:10.1186/s13068-021-02005-w · Cited by 36
A dual gene-specific mutator system installs all transition mutations at similar frequencies in vivo
Seo, D., Koh, B., Eom, G.-E., Kim, H. W., & Kim, S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad266 · Cited by 35
Split complementation of base editors to minimize off-target edits
Xiong, X., Liu, K., Li, Z., Xia, F., Ruan, X.-M., He, X., & Li, J. (2023) · Nature Plants · doi:10.1038/s41477-023-01540-8 · Cited by 34
Base editing for reprogramming cyanobacterium Synechococcus elongatus
Wang, S.-Y., Li, X., Wang, S.-G., & Xia, P.-F. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2022.11.005 · Cited by 31
PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells
Hiramoto, T., Kashiwakura, Y., Hayakawa, M., Baatartsogt, N., Kamoshita, N., Abe, T., Inaba, H., Nishimasu, H., Uosaki, H., Hanazono, Y., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00286-w · Cited by 31
The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders
Moghaddas, F., & Masters, S. L. (2018) · Clinical Science · doi:10.1042/cs20171498 · Cited by 31
CRISPR-Cas nucleases and base editors for plant genome editing
Gürel, F., Zhang, Y., Sretenovic, S., & Qi, Y. (2019) · aBIOTECH · doi:10.1007/s42994-019-00010-0 · Cited by 36
Recent Advances in Systems Metabolic Engineering Strategies for the Production of Biopolymers
Sohn, Y. J., Kim, H. T., Jo, S. Y., Song, H. M., Baritugo, K., Pyo, J., Choi, J., Joo, J. C., & Park, S. J. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-019-0508-5 · Cited by 31
Optimizing Calcium Detection Methods in Animal Systems: A Sandbox for Synthetic Biology
Li, E. S., & Saha, M. S. (2021) · Biomolecules · doi:10.3390/biom11030343 · Cited by 31
Kim, M. S., Kim, H.-R., Jeong, D.-E., & Choi, S.-K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.691839 · Cited by 36
Recent Advances in the Production of Genome-Edited Rats
Sato, M., Nakamura, S., Inada, E., & Takabayashi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052548 · Cited by 33
Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis
Ipsaro, J. J., Shen, C., Arai, E., Xu, Y., Kinney, J. B., Joshua‐Tor, L., Vakoc, C. R., & Shi, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172177 · Cited by 31
Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Xu, F., Zheng, C., Xu, W., Zhang, S., Liu, S., Chen, X., & Yao, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364135 · Cited by 34
CRISPR Tools for Engineering Prokaryotic Systems: Recent Advances and New Applications
Burbano, D. A., Kiattisewee, C., Karanjia, A. V., Cardiff, R. A. L., Faulkner, I., Sugianto, W., & Carothers, J. M. (2024) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-100522-114706 · Cited by 36
Hao, W., Cui, W., Suo, F., Han, L., Cheng, Z., & Zhou, Z. (2022) · Chemical Science · doi:10.1039/d2sc05824c · Cited by 33
Kuroiwa, K., Danilo, B., Perrot, L., Thenault, C., Veillet, F., Delacôte, F., Duchateau, P. N., Nogué, F., Mazier, M., & Gallois, J. (2023) · Plant Biotechnology Journal · doi:10.1111/pbi.14003 · Cited by 30
Commentary: Programmable base editing of A·T to G·C in genomic DNA without DNA cleavage
Matsoukas, I. G. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00021 · Cited by 36
Thomson, M. J., Biswas, S., Τσακιρπάλογλου, Ν., & Septiningsih, E. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126565 · Cited by 36
Xia, Y., Li, Y., Shen, W., Yang, H., & Chen, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015310 · Cited by 31
Allemailem, K. S., Almatroudi, A., Rahmani, A. H., Alrumaihi, F., Alradhi, A. E., Al-Subaiyel, A., Algahtani, M., Almousa, R. M., Mahzari, A., Sindi, A. A. A., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s455574 · Cited by 40
Harnessing the evolving CRISPR/Cas9 for precision oncology
Li, T., Li, S., Kang, Y., Zhou, J., & Yi, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05570-4 · Cited by 39
Song, Y., Zhang, Y., Chen, M., Deng, J., Sui, T., Lai, L., & Li, Z. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.041 · Cited by 30
RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing
Chen, G., Katrekar, D., & Mali, P. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00046 · Cited by 29
Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis—Learning from Other Diseases
Mention, K., Santos, L., & Harrison, P. T. (2019) · Genes · doi:10.3390/genes10050387 · Cited by 34
In vivo continuous evolution of metabolic pathways for chemical production
Tan, Z. L., Zheng, X., Wu, Y., Jian, X., Xing, X., & Zhang, C. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1132-y · Cited by 34
Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing
Shin, H. R., See, J.-E., Kweon, J., Kim, H. S., Sung, G., Park, S., Jang, A.-H., Jang, G., Choi, K., Kim, I., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab052 · Cited by 32
A general theoretical framework to design base editors with reduced bystander effects
Wang, Q., Yang, J., Zhong, Z., Vanegas, J. A., Gao, X., & Kolomeisky, A. B. (2021) · Nature Communications · doi:10.1038/s41467-021-26789-5 · Cited by 32
Development of a genome-targeting mutator for the adaptive evolution of microbial cells
Eom, G.-E., Lee, H., & Kim, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1244 · Cited by 29
Application of CRISPR/Cas9 in Rapeseed for Gene Function Research and Genetic Improvement
Tian, Q. C., Li, B., Feng, Y., Zhao, W., Huang, J., & Chao, H. (2022) · Agronomy · doi:10.3390/agronomy12040824 · Cited by 36
CRISPR Tools for Systematic Studies of RNA Regulation
Engreitz, J., Abudayyeh, O. O., Gootenberg, J. S., & Zhang, F. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035386 · Cited by 33
Xie, J., Zhuang, Z., Gou, S., Zhang, Q., Wang, X., Lan, T., Lian, M., Li, N., Liang, Y., Ouyang, Z., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad687 · Cited by 33
He, Y., Han, Y., Ma, Y., Liu, S., Fan, T., Liang, Y., Tang, X., Zheng, X., Wu, Y., Zhang, T., et al. (2024) · Plant Biotechnology Journal · doi:10.1111/pbi.14363 · Cited by 29
Bzhilyanskaya, V., Ma, L., Liu, S., Fox, L. R., Whittaker, M. N., Meis, R. J., Choi, U., Lawson, A., Ma, M., Theobald, N., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj6779 · Cited by 28
A piggyBac‐mediated transgenesis system for the temporary expression of CRISPR/Cas9 in rice
Nishizawa‐Yokoi, A., & Toki, S. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13559 · Cited by 28
Genome editing for crop improvement: A perspective from India
Bhattacharya, A., Parkhi, V., & Char, B. R. (2021) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-021-10184-2 · Cited by 38
Deep distributed computing to reconstruct extremely large lineage trees
Konno, N., Kijima, Y., Watano, K., Ishiguro, S., Ono, K., Tanaka, M., Mori, H., Masuyama, N., Pratt, D. R., Ideker, T., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01111-2 · Cited by 33
Self-citationProgrammable Single and Multiplex Base-Editing in Bombyx mori Using RNA-Guided Cytidine Deaminases
Li, Y., Ma, S., Sun, L., Zhang, T., Chang, J., Lü, W., Chen, X., Liu, Y., Wang, X., Shi, R., et al. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200134 · Cited by 30
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 39
Evolution of CRISPR towards accurate and efficient mammal genome engineering
Ryu, S.-M., Hur, J. W., & Kim, K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.8.149 · Cited by 29
Strategies for Developing CRISPR‐Based Gene Editing Methods in Bacteria
Wu, Z., Wang, Y., Zhang, Y., Chen, W., Wang, Y., & Ji, Q. (2019) · Small Methods · doi:10.1002/smtd.201900560 · Cited by 27
Komatsu, A., Ohtake, M., Shimatani, Z., & Nishida, K. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00925 · Cited by 27
Self-citationGuyon‐Debast, A., Alboresi, A., Terret, Z., Charlot, F., Berthier, F., Vendrell‐Mir, P., Casacuberta, J., Veillet, F., Morosinotto, T., Gallois, J., et al. (2021) · New Phytologist · doi:10.1111/nph.17171 · Cited by 31
CRISPR/Cas based gene editing: marking a new era in medical science
Prasad, K. M., George, A., Ravi, N. S., & Mohankumar, K. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06479-7 · Cited by 35
Sato, Y. (2021) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c21-00705 · Cited by 30
Automated high-throughput genome editing platform with an AI learning in situ prediction model
Li, S., An, J., Li, Y., Zhu, X., Zhao, D., Wang, L., Sun, Y., Yang, Y., Bi, C., Zhang, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35056-0 · Cited by 39
Expanded palette of RNA base editors for comprehensive RBP-RNA interactome studies
Medina-Muñoz, H. C., Kofman, E. R., Jagannatha, P., Boyle, E. A., Yu, T., Jones, K. L., Mueller, J. R., Lykins, G. D., Doudna, A. T., Park, S. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45009-4 · Cited by 29
Progress in the application of CRISPR: From gene to base editing
Wu, W., Yang, Y., & Lei, H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21537 · Cited by 34
Development of multiplexed orthogonal base editor (MOBE) systems
Cowan, Q. T., Gu, S., Gu, W., Ranzau, B. L., Simonson, T. S., & Komor, A. C. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02240-0 · Cited by 26
Plant genome editing: CRISPR, base editing, prime editing, and beyond
Xie, Y., Haq, S. I. U., Jiang, X., Zheng, D., Feng, N., Wang, W., He, J., & Qiu, Q. (2022) · Grassland Research · doi:10.1002/glr2.12034 · Cited by 31
Saturation profiling of drug-resistant genetic variants using prime editing
Kim, Y., Oh, H.-C., Lee, S., & Kim, S. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02465-z · Cited by 33
In vivo targeted single-nucleotide editing in zebrafish
Tanaka, S., Yoshioka, S., Nishida, K., Hosokawa, H., Kakizuka, A., & Maegawa, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-29794-9 · Cited by 25
Self-citationEfficient targeted mutation of genomic essential genes in yeast Saccharomyces cerevisiae
Yang, S. L., Cao, X. D., Yu, W., Li, S., & Zhou, Y. J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10405-5 · Cited by 24
BE4max and AncBE4max Are Efficient in Germline Conversion of C:G to T:A Base Pairs in Zebrafish
Carrington, B., Weinstein, R. N., & Sood, R. B. (2020) · Cells · doi:10.3390/cells9071690 · Cited by 31
CRISPR/Cas9-mediated mutagenesis at microhomologous regions of human mitochondrial genome
Wang, B., Lv, X., Wang, Y., Wang, Z., Liu, Q., Lü, B., Liu, Y., & Gu, F. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1819-8 · Cited by 30
Zhang, Y., Yun, K., Huang, H., Tu, R., Hua, E., & Wang, M. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00563 · Cited by 28
Singh, J., Sharma, D., Brar, G. S., Sandhu, K. S., Wani, S. H., Kashyap, R., Kour, A., & Singh, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07741-2 · Cited by 26
Engineering plant immune circuit: walking to the bright future with a novel toolbox
Vuong, U. T., Iswanto, A. B. B., Nguyen, Q., Kang, H., Lee, J., Moon, J. M., & Kim, S. H. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13916 · Cited by 27
Applications and prospects of genome editing in plant fatty acid and triacylglycerol biosynthesis
Park, M., & Kim, H. U. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.969844 · Cited by 29
Hao, W., Cui, W., Liu, Z., Suo, F., Wu, Y., Han, L., & Zhou, Z. (2024) · Advanced Science · doi:10.1002/advs.202309767 · Cited by 32
Base editors: a powerful tool for generating animal models of human diseases
Lu, Z., & Huang, X. (2018) · Cell Stress · doi:10.15698/cst2018.10.156 · Cited by 26
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing
Chadwick, A. C., & Musunuru, K. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0668-8 · Cited by 26
Single nucleotide editing without DNA cleavage using CRISPR/Cas9‐deaminase in the sea urchin embryo
Shevidi, S., Uchida, A., Schudrowitz, N., Wessel, G. M., & Yajima, M. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24586 · Cited by 25
Genome-wide specificity of dCpf1 cytidine base editors
Kim, D., Lim, K., Kim, J., & Kim, J. (2020) · Nature Communications · doi:10.1038/s41467-020-17889-9 · Cited by 26
Gallego, C., Gonçalves, M. A. F. V., & Wijnholds, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00838 · Cited by 27
Efficient silencing of hepatitis B virus S gene through CRISPR‐mediated base editing
Zhou, H., Wang, X., Steer, C. J., Song, G., & Niu, J. (2022) · Hepatology Communications · doi:10.1002/hep4.1933 · Cited by 27
Liu, Y., Wang, R., Liu, J., Lu, H., Li, H., Wang, Y., Ni, X., Li, J., Guo, Y., Ma, H., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq2157 · Cited by 31
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases
Hansen, S., McClements, M. E., Corydon, T. J., & MacLaren, R. E. (2023) · Cells · doi:10.3390/cells12030440 · Cited by 25
Ge, L., Dong, X., Gong, X., Kang, J., Zhang, Y., & Quan, F. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.043 · Cited by 30
Lubroth, P., Colasante, G., & Lignani, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.632522 · Cited by 28
Wang, Q., Capelletti, S., Liu, J., Janssen, J. M., & Gonçalves, M. A. F. V. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae057 · Cited by 26
Assisted Reproductive Techniques and Genetic Manipulation in the Common Marmoset
Park, J. E., & Sasaki, E. (2020) · ILAR Journal · doi:10.1093/ilar/ilab002 · Cited by 25
Harnessing the yeast Saccharomyces cerevisiae for the production of fungal secondary metabolites
Wang, G., Kell, D. B., & Borodina, I. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200137 · Cited by 27
Xin, Q., Chen, Y., Chen, Q., Wang, B., & Pan, L. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01832-2 · Cited by 24
CRISPR editing in biological and biomedical investigation
Huang, J., Wang, Y., & Zhao, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26141 · Cited by 27
Increasing fidelity and efficiency by modifying cytidine base-editing systems in rice
Qin, R., Liao, S., Li, J., Li, H., Liu, X., Yang, J., & Wei, P. (2019) · The Crop Journal · doi:10.1016/j.cj.2019.04.007 · Cited by 27
Rogers, G. L., Chen, H.-Y., Morales, H., & Cannon, P. M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.019 · Cited by 24
Base editors: modular tools for the introduction of point mutations in living cells
Evanoff, M., & Komor, A. C. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190088 · Cited by 30
Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
Wang, P., Bailin, P. L., Zhu, M., Han, R. Y., Guo, S., & Han, R. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.11.010 · Cited by 30
Genome-scale exon perturbation screens uncover exons critical for cell fitness
Xiao, M., Damodaran, A. P., Kumari, B., Dickson, E., Xing, K., On, T. A., Parab, N., King, H. E., Perez, A. R., Guiblet, W. M., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.05.024 · Cited by 26
Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system
Wang, L., & Han, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38588 · Cited by 28
CRISPR-Cas9-AID base editor is a powerful gain-of-function screening tool
Kuscu, C., & Adli, M. (2016) · Nature Methods · doi:10.1038/nmeth.4076 · Cited by 23
Fix, S. M., Jazaeri, A. A., & Hwu, P. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1083 · Cited by 26
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s
Hou, S., Lee, J. M., Myint, W., Matsuo, H., Yılmaz, N. K., & Schiffer, C. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100909 · Cited by 23
Jiang, G., Wang, J., Zhao, D., Chen, X., Pu, S., Zhang, C., Li, J., Li, Y., Yang, J., Li, S., et al. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00293 · Cited by 26
Tips, Tricks, and Potential Pitfalls of CRISPR Genome Editing in Saccharomyces cerevisiae
Antony, J. S., Hinz, J. M., & Wyrick, J. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.924914 · Cited by 28
Li, Z., Ma, R., Liu, D., Wang, M., Zhu, T., & Deng, Y. (2022) · Plant Science · doi:10.1016/j.plantsci.2022.111400 · Cited by 25
Development of Base Editors for Simultaneously Editing Multiple Loci in Lactococcus lactis
Tian, K., Hong, X., Guo, M., Li, Y., Wu, H., Caiyin, Q., & Qiao, J. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00561 · Cited by 26
Wang, Y., Zhao, D., Sun, L., Wang, J., Fan, L., Cheng, G., Zhang, Z., Ni, X., Feng, J., Wang, M., et al. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00265 · Cited by 26
Applications of Anti-CRISPR Proteins in Genome Editing and Biotechnology
Kraus, C., & Sontheimer, E. J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168120 · Cited by 27
Progress and Prospects of Gene Editing in Pluripotent Stem Cells
Zhang, Z., Bao, X., & Lin, C. (2023) · Biomedicines · doi:10.3390/biomedicines11082168 · Cited by 25
Perspective: functional genomics towards new biotechnology in medicinal plants
Yamazaki, M., Rai, A., Yoshimoto, N., & Saito, K. (2018) · Plant Biotechnology Reports · doi:10.1007/s11816-018-0476-9 · Cited by 26
Acceleration of cancer science with genome editing and related technologies
Sakuma, T., & Yamamoto, T. (2018) · Cancer Science · doi:10.1111/cas.13832 · Cited by 24
Generation of imidazolinone herbicide resistant trait in Arabidopsis
Dong, H., Wang, D., Bai, Z., Yuan, Y., Yang, W., Zhang, Y., Ni, H., & Jiang, L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233503 · Cited by 24
Metadata
- Authors
- Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., Shimatani, Z., & Kondo, A.
- Affiliations
- Kobe University (JP)
- Keio University (JP)
- Shizuoka University (JP)
- Corresponding author
- Kondo, Akihiko
- ORCID
- Venue
- Science
- Published
- 2016-09-16
- Volume
- 353
- Issue
- 6305
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2480829753
- Cited by
- 1,349
- References
- 27
- Citations by year
- 2026: 69 · 2025: 124 · 2024: 151 · 2023: 152 · 2022: 181 · 2021: 157 · 2020: 167 · 2019: 137 · 2018: 112 · 2017: 88 · 2016: 10
- FWCI
- 60.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports and Technology (MEXT) of Japan
- Ministry of Economy, Trade and Industry (METI), Japan
- JSPS KAKENHI (26119710, 16K14654)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- activation-induced cytidine deaminase, CRISPR/Cas9, dCas9, sea lamprey, somatic hypermutation, R-loops, site-directed mutagenesis, genome editing, immunoglobulin variable region, affinity maturation
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, AICDA (Activation-Induced Cytidine Deaminase), Alleles, Animals, Bacteria, Bacterial Proteins, Cricetulus, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, Endonucleases, Enzyme Inhibitors, Immune System, RNA, Saccharomyces cerevisiae, Vertebrates, CHO Cells, Point Mutation, Gene Targeting, Uracil-DNA Glycosidase, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.